Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update - Replacement

2 Aug 2022 08:59

RNS Number : 5961U
Biome Technologies PLC
02 August 2022
 

The following amendment has been made to the Trading Update announcement released at 07:00 on 2 August 2022 under RNS No. 5230U.

In the Cash and liquidity section, the announcement incorrectly stated the reference date for the comparative cash balance as being 30 June 2022. The correct comparative cash balance reference date is 30 June 2021. 

All other details remain unchanged. The full corrected announcement is set out below.

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

2 August 2022

 

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides an unaudited Trading Update for the quarter ended 30 June 2022. The Company's unaudited interim results are expected to be announced on 22 September 2022.

 

Group revenues for the quarter ended 30 June 2022 were slightly lower than management expectations at £1.4m (Q2 2021: £1.3m) as delays of materials from suppliers constrained both Divisions. It is expected that the revenues delayed from Q2 will be recovered during Q3 2022.

 

Bioplastics Division

 

The Division's revenues for Q2 were £1.0m (Q2 2021: £1.1m). Management continues to anticipate substantial revenue growth from this Division during H2 2022. This growth is underpinned by supply chain preparation and stocking by several of the Division's customers which are planning product launches in H1 2023 and based on our new "home compostable" bio-based and biodegradable materials that are subject to the protection of a pending patent. Enquiries in the bioplastics space remain buoyant, although our customers continue to face supply chain challenges as they deploy new products.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies Division in Q2 were £0.2m (Q2 2021: £0.2m). The Division's strong orderbook had been expected to convert to higher revenue levels in Q2. However, component shortages, particularly of electronic parts, have impeded the build out of the significant RF contracts that were announced in late 2021 and early 2022. Good progress has already been made in early Q3 and we expect for the Division's delayed revenues to be fully recovered in H2.

 

Cash and liquidity

 

The Group had a cash balance as at 30 June 2022 of £0.7m (30 June 2021: £1.4m) and no bank debt.

 

We are pleased to announce that the Group has entered into a receivables financing agreement with Accelerated Payments Limited. This highly flexible facility has been put in place to provide working capital funding, as and when required, as we look to grow the business over the coming months and years.

 

Group Outlook

 

The Board's view of the Group's performance remains in line with current market expectations.

 

 

-Ends-

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZGGRNZKGZZG
Date   Source Headline
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSContract
17th Mar 20217:00 amRNSUpdate on biodegradable tree shelter project
16th Mar 20217:00 amRNSBiome commits to UN Race to Zero climate campaign
28th Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSUpdate on biodegradable tree shelter project
31st Dec 20201:30 pmRNSTotal Voting Rights
15th Dec 20207:00 amRNSBiome's RF division gains traction
11th Dec 20208:05 amRNSAdmission of Subscription Shares
6th Nov 20204:41 pmRNSSecond Price Monitoring Extn
6th Nov 20204:35 pmRNSPrice Monitoring Extension
4th Nov 20207:00 amRNSBiome starts biodegradable tree shelter project
30th Oct 20205:00 pmRNSTotal Voting Rights
30th Oct 20207:00 amRNSDirector/PDMR Shareholding
29th Oct 20207:01 amRNSAppointment of Group Chief Financial Officer
29th Oct 20207:00 amRNSTrading Update
22nd Oct 202012:28 pmRNSHolding(s) in Company
19th Oct 20202:17 pmRNSHolding(s) in Company
12th Oct 20204:07 pmRNSResult of General Meeting
1st Oct 202010:55 amRNSHolding(s) in Company
24th Sep 20207:05 amRNSProposed Fundraise of £1.1 million & Notice of GM
24th Sep 20207:00 amRNSInterim Results
26th Aug 20207:00 amRNSGrant funding from Innovate UK
19th Aug 20207:00 amRNSOrder for compostable bioplastic for coffee pods
30th Jul 20207:00 amRNSTrading Update
25th Jun 20203:46 pmRNSResult of Annual General Meeting
2nd Jun 202010:35 amRNSNotice of Annual General Meeting 2020
22nd Apr 20207:00 amRNSTrading Update
20th Apr 20202:16 pmRNSAnnual Report and Accounts
16th Apr 20207:00 amRNSFinal Results 2019
25th Mar 20207:00 amRNSUpdate re Final Results, 2019 Annual Report & AGM
13th Feb 20204:01 pmRNSNotification of awards under the 2017 LTIP
30th Jan 20204:10 pmRNSShare option awards in lieu of historic bonuses
30th Jan 20207:00 amRNSTrading statement and Board change
4th Nov 20197:00 amRNSBiome to present at Mello London 2019
31st Oct 20195:30 pmRNSTotal Voting Rights
31st Oct 20197:00 amRNSTrading update
30th Sep 20193:04 pmRNSResult of General Meeting
12th Sep 20197:05 amRNSProposed Placing to raise £1.3 million
12th Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSTrading Update
25th Jun 20199:17 amRNSLong Term Incentive Plan Second Vesting
17th Jun 20194:12 pmRNSDirector/PDMR/PCA Shareholding
14th Jun 20197:00 amRNSBioplastics Product Update
24th Apr 20191:59 pmRNSResult of Annual General Meeting
24th Apr 20197:00 amRNSTrading Update
4th Apr 201912:20 pmRNSDirector/PDMR/PCA Shareholding
29th Mar 20199:22 amRNSNotice of AGM and Annual Report
28th Mar 20197:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.